Skip to content
Publicly Available Published by De Gruyter May 27, 2020

Low levels of total and ionized calcium in blood of COVID-19 patients

  • Fabrizio Cappellini ORCID logo EMAIL logo , Rinaldo Brivio , Marco Casati , Annalisa Cavallero , Ernesto Contro and Paolo Brambilla

To the Editor,

As of April 27, 2020, the SARS-CoV-2 pandemic caused worldwide more than 3 million cases with more than 200,000 confirmed deaths. Italy, following USA and followed by Spain, is the country with a higher number of deaths, more than 26,000, with most of them occurring in Lombardia region [1]. Worldwide, hospital organizations have been deeply changed in the recent months; San Gerardo Hospital (Monza, Italy) increased its intensive care unit bed availability by almost 300% and a total of 20 wards were readdressed for the care of COVID-19 patients.

Patients admitted to the emergency department (ED) with clinical signs and symptoms suggestive of COVID-19 have been investigated with nasopharyngeal swabs for SARS-CoV-2 (RT-qPCR) plus biochemistry, hematology and coagulation test panels. Overall, we found an increase in patients who had a reduction in serum total calcium (TCa, mmol/L) and whole blood actual ionized calcium (Ca2+, mmol/L) levels. Therefore, we retrospectively evaluated TCa and Ca2+ in consecutive adult patients admitted to the ED during the period February 27th–March 30th and suspected to be positive for SARS-CoV-2 after evaluation of anamnestic data, and physical and diagnostic examination made by the ED clinicians. We took into consideration all cases for whom the swab had been performed on the same day of admission to ED, and TCa and Ca2+ had been measured (within 30 min for TCa and immediately for Ca2+), on samples obtained during the first ED examination. The aim was to give a realistic picture of the calcium measurements according to subsequent stratification of subjects in positive or negative to infection by the results of the nasopharyngeal swabs. The study population included 585 patients: 386 males and 199 females, 420 positive and 165 negative to SARS-CoV-2, with mean and median age equal to 66 years (range 18–101 years).

TCa was measured photometrically (Cobas c702, Roche Diagnostics, Mannheim, Germany) on serum obtained after centrifugation of whole blood (10 min at 3000×g at room temperature) collected in plastic tubes with gel separator and clot activator (SST II ADVANCE, REF 366881 Becton Dickinson). Ca2+ was measured by direct potentiometry (RP500, Siemens Healthcare, Erlangen, Germany) on arterial blood sampling syringes with dry lithium heparin (Smiths Medical – Portex, REF 4043E). Cumulative frequency distribution plot revealed that COVID-19 patients had lower TCa (Figure 1A) and Ca2+ (Figure 1B) concentrations with respect to non-COVID-19 patients. TCa medians and interquartile ranges for COVID-19 and non-COVID-19 patients were 2.15 (2.05–2.23) and 2.28 (2.15–2.38), respectively, and for Ca2+ were 1.12 (1.09–1.15) and 1.17 (1.13–1.21), respectively. The Mann-Whitney test was performed to compare medians that resulted to be statistically different, p<0.0001. Given that we observed a decrease for TCa and Ca2+ with increasing age and lower values in males with respect to females, we performed a multiple regression analysis in order to test if: (a) positivity to SARS-Cov-2, (b) age and (c) gender of patients could independently affect TCa and Ca2+. For TCa, the SARS-CoV-2 positivity (coefficient: −0.1247, p<0.0001), age (coefficient: −0.0015, p=0.0001) and male gender (coefficient: −0.0337, p=0.0039) significantly and negatively affected the analyte concentration; for Ca2+, the SARS-CoV-2 positivity (coefficient: −0.0486 p<0.0001), but not age (p=0.0747) and gender (p=0.0895), affected the analyte concentration. We performed an analysis of covariance (ANCOVA) with the aim to compare TCa and Ca2+ means in COVID-19 and non-COVID-19 adjusting for age and gender. In COVID-19, TCa was equal to 2.14 (95% CI 2.13–2.15) and Ca2+ was equal to 1.12 (95% CI 1.12–1.13). In non-COVID-19, TCa was equal to 2.27 (95% CI 2.25–2.29) and Ca2+ was equal to 1.17 (1.16–1.18). Both for TCa and Ca2+, the differences between groups are statistically significant, p<0.0001. Statistical analyses were performed using MedCalc for Windows (version 18.11.6) on an anonymized dataset which did not require the review of the Ethics Committee.

Figure 1: Calcium values distribution in the study population.
Cumulative frequency distribution plot of TCa (A) and Ca2+ (B) in COVID-19 and non-COVID-19 patients admitted to ED with clinical suspect of SARS-CoV-2 infection. Red and green rectangles correspond to the median TCa and Ca2+ values observed in COVID-19 and non-COVID-19 patients, respectively.
Figure 1:

Calcium values distribution in the study population.

Cumulative frequency distribution plot of TCa (A) and Ca2+ (B) in COVID-19 and non-COVID-19 patients admitted to ED with clinical suspect of SARS-CoV-2 infection. Red and green rectangles correspond to the median TCa and Ca2+ values observed in COVID-19 and non-COVID-19 patients, respectively.

To the best of our knowledge, these findings are unique in published literature; many studies [2], [3], [4], [5] reported abnormalities in laboratory tests of COVID-19 patients (decrease in lymphocyte count, platelet count and albumin, and increase in neutrophil count, LDH, ALT, AST, total bilirubin, creatinine, cardiac troponins, D-dimer, PT, procalcitonin and CRP), but calcium alterations have not yet been observed. We evaluated blood pH for all subjects in order to test the chance that the Ca2+ reduction could be caused by a pH increase in COVID-19 patients consequent to hyperventilation. We would rule out this possibility because (a) the mean pH values in COVID-19 and non-COVID-19 groups are similar (7.43 and 7.47, respectively), and (b) we have repeated ANCOVA adding pH as covariate observing that the difference in Ca2+ between groups still remains statistically significant (p<0.0001). Moreover, we found the same results for TCa and Ca2+ leading us to think that the reduction observed is independent of the albumin decrease seen in COVID-19 patients.

Serum calcium modifications may be due to alterations in intestinal absorption, imbalance in regulatory mechanism involving PTH and D-Vitamin, or a direct effect caused by SARS-CoV-2. In viral infections, Ca2+ is essential for virus structure formation, entry, gene expression, virion maturation and release [6]. Experiments in vitro and in animal models infected with SARS-CoV demonstrated that SARS-CoV E gene encodes a small transmembrane protein with ion channel activity that is highly synthesized during infection and that is mainly localized in the Golgi apparatus and endoplasmic reticulum Golgi apparatus intermediate compartment (ERGIC). These ion channels are permeable to Ca2+, and it was demonstrated that calcium homeostasis alteration within the cell could promote the activation of inflammatory pathways leading to increased levels of IL-1b, TNF and IL-6, linked to lung cell damage and edema accumulation [7], [8]. Given the high similarity between SARS-CoV-2 and SARS-CoV genomes, it is likely that the mechanisms seen in SARS-CoV could be the same for SARS-CoV-2. For this reason, our observation could be a direct consequence of a known alteration of intracellular calcium homeostasis used by the virus as a strategy in its favor.

Further studies should be performed with the aim to confirm our findings, also taking into account all the factors that could affect calcium homeostasis, and to evaluate if calcium measurements can be used as a prognostic and/or severity marker in patients with SARS-CoV-2 infection.

  1. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  2. Employment or leadership: None declared.

  3. Honorarium: None declared.

  4. Research funding: None declared.

  5. Competing interests: Authors state no conflict of interest.

  6. Ethical approval: The local Institutional Review Board deemed the study exempt from review.


1. Roser M, Ritchie H, Ortiz-Ospina E. Coronavirus Disease (COVID-19) – Statistics and Research. Accessed: 27 Apr 2020.Search in Google Scholar

2. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020;58:1131–4.10.1515/cclm-2020-0198Search in Google Scholar PubMed

3. Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020;58:1116–20.10.1515/cclm-2020-0188Search in Google Scholar PubMed

4. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 2020. Doi: 10.1016/j.cca.2020.03.022. [Epub ahead of print].10.1016/j.cca.2020.03.022Search in Google Scholar PubMed PubMed Central

5. Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta 2020. Doi: 10.1016/j.cca.2020.03.004. [Epub ahead of print].10.1016/j.cca.2020.03.004Search in Google Scholar PubMed PubMed Central

6. Zhou Y, Frey TK, Yang JJ. Viral calciomics: interplays between Ca2+ and virus. Cell Calcium 2009;46:1–17.10.1016/j.ceca.2009.05.005Search in Google Scholar PubMed PubMed Central

7. Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA, Fernandez-Delgado R, et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog 2014;10:e1004077.10.1371/journal.ppat.1004077Search in Google Scholar PubMed PubMed Central

8. Nieto-Torres JL, Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA, Castaño-Rodriguez C, Fernandez-Delgado R, et al. Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology 2015;485:330–9.10.1016/j.virol.2015.08.010Search in Google Scholar PubMed PubMed Central

Received: 2020-04-28
Accepted: 2020-05-13
Published Online: 2020-05-27
Published in Print: 2020-08-27

©2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 28.9.2023 from
Scroll to top button